Oncimmune Holdings (LSE:ONC) Days Sales Outstanding : 167.80 (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Days Sales Outstanding?

Oncimmune Holdings's average Accounts Receivable for the six months ended in Feb. 2024 was £1.09 Mil. Oncimmune Holdings's Revenue for the six months ended in Feb. 2024 was £1.19 Mil. Hence, Oncimmune Holdings's Days Sales Outstanding for the six months ended in Feb. 2024 was 167.80.

The historical rank and industry rank for Oncimmune Holdings's Days Sales Outstanding or its related term are showing as below:

LSE:ONC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.1 Med: 161.46 Max: 1036.07
Current: 362.49

During the past 12 years, Oncimmune Holdings's highest Days Sales Outstanding was 1036.07. The lowest was 52.10. And the median was 161.46.

LSE:ONC's Days Sales Outstanding is ranked worse than
89.98% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs LSE:ONC: 362.49

Oncimmune Holdings's Days Sales Outstanding declined from Feb. 2023 (621.46) to Feb. 2024 (167.80).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Oncimmune Holdings Days Sales Outstanding Historical Data

The historical data trend for Oncimmune Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Days Sales Outstanding Chart

Oncimmune Holdings Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

Aug23

Days Sales Outstanding

Get a 7-Day Free Trial

401.29

389.02

109.15

431.15

1,036.07

Oncimmune Holdings Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24
Days Sales Outstanding	Get a 7-Day Free Trial															492.62	646.56	621.46	5,725.94	167.80

Competitive Comparison of Oncimmune Holdings's Days Sales Outstanding

For the Biotechnology subindustry, Oncimmune Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Days Sales Outstanding falls into.

Oncimmune Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oncimmune Holdings's Days Sales Outstanding for the fiscal year that ended in Aug. 2023 is calculated as

	Days Sales Outstanding (A: Aug. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: May. 2022 )	+	Accounts Receivable (A: Aug. 2023 ))	/	count )	/	Revenue (A: Aug. 2023 )	*	Days in Period
=	( (6.219	+	0.321)	/	2 )	/	1.152	*	365
=	3.27					/	1.152	*	365
=	1,036.07

Oncimmune Holdings's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

	Days Sales Outstanding (Q: Feb. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Aug. 2023 )	+	Accounts Receivable (A: Feb. 2024 ))	/	count )	/	Revenue (A: Feb. 2024 )	*	Days in Period
=	( (0.321	+	1.86)	/	2 )	/	1.186	*	365 / 2
=	1.0905					/	1.186	*	365 / 2
=	167.80

Oncimmune Holdings (LSE:ONC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Oncimmune Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings (LSE:ONC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

OCY:Germany

Address

1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB

Website

https://www.oncimmune.com

Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.

Oncimmune Holdings (LSE:ONC) Headlines

No Headlines